Mission Therapeutics
PrivateLast Round
Series D
Extension
Oct 15, 2025
Est. Valuation
$115.4M
Total Funding Raised
$193.3M
Company Overview
Mission Therapeutics is a pharmaceutical research and drug discovery company focused on developing innovative treatments by harnessing deubiquitylating enzymes and advancing our understanding of human cell biology to improve outcomes for patients with life-threatening diseases, particularly cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mission Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Mission Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Oct 15, 2025 | ||||
| Grant | Jul 2, 2024 | ||||
| Series D | Mar 14, 2024 | ||||
| Series C Extension | Jul 6, 2020 | ||||
| Series C | Feb 2, 2016 | ||||
Series B | Nov 18, 2013 |
Mission Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Series C Extension, Series D, Series D Extension |
| Parkinson's UK | Grant |
| Woodford Investment Management | Series C |
| Roche Venture Fund | Series B, Series C Extension, Series D, Series D Extension, Series A, Series C |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Imperial Innovations | Series A, Series B, Series C |
| Pfizer Ventures | Series D, Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2025
Preclinical laboratory operations in Cambridge, UK are closing.
Mission Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mission Therapeutics's valuation, stock price, and market status.
